A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma

Citation:

Assal RA, Elemam NM, Mekky RY, Attia AA, Soliman AH, Gomaa AI, Efthimiadou EK, Braoudaki M, Fahmy SA, Youness RA. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma. Translational Oncology [Internet]. 2024;45.

Notes:

Export Date: 10 November 2025; Cited By: 16

Website

Contact Details

National and Kapodistrian University of Athens
(+30) 210-7274858
Zografou
Athens, ZipCode 15772
efthim@chem.uoa.gr

<embed>

Recent Publications

Engineering of two-in-one Fe@Eu nanoparticles through hydrothermal synthesis: bimetallic hybrids for theranostic applications
Hybrid silver-iron oxide nanoflowers: morphological tailoring, application as CT agents, and exploitation of induced apoptosis in glioblastoma treatment
Platelet-Rich Plasma (PRP) Mitigates Silver Nanoparticle (AgNP)-Induced Pulmonary Fibrosis via iNOS/CD68/CASP3/TWIST1 Regulation: An Experimental Study and Bioinformatics Analysis †

2025 (5)
2024 (5)

Eleni Efthimiadou

Assistant Professor, Chemistry

A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma

Citation:

Notes:

Contact Details

Recent Publications

Publications per year